Highly selective inhibition of histone demethylases by de novo macrocyclic peptides
The JmjC histone demethylases (KDMs) are linked to tumour cell proliferation and are current cancer targets; however, very few highly selective inhibitors for these are available. Here we report cyclic peptide inhibitors of the KDM4A-C with selectivity over other KDMs / 2OG oxygenases, including clo...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Nature Publishing Group
2017
|
| _version_ | 1826283487427035136 |
|---|---|
| author | Kawamura, A Münzel, M Kojima, K Yapp, C Bhushan, B Goto, Y Tumber, A Katoh, T King, O Passioura, T Walport, L Hatch, S Madden, S Müller, S Brennan, P Chowdhury, R Hopkinson, R Suga, H Schofield, C |
| author_facet | Kawamura, A Münzel, M Kojima, K Yapp, C Bhushan, B Goto, Y Tumber, A Katoh, T King, O Passioura, T Walport, L Hatch, S Madden, S Müller, S Brennan, P Chowdhury, R Hopkinson, R Suga, H Schofield, C |
| author_sort | Kawamura, A |
| collection | OXFORD |
| description | The JmjC histone demethylases (KDMs) are linked to tumour cell proliferation and are current cancer targets; however, very few highly selective inhibitors for these are available. Here we report cyclic peptide inhibitors of the KDM4A-C with selectivity over other KDMs / 2OG oxygenases, including closely related KDM4D/E isoforms. Crystal structures and biochemical analyses of one of the inhibitors (CP2) with KDM4A reveals that CP2 binds differently to, but competes with, histone substrates in the active site. Substitution of the active site binding arginine of CP2 to N-ε-trimethyl-lysine or methylated-arginine results in cyclic-peptide substrates, indicating that KDM4s may act on non-histone substrates. Targeted modifications to CP2 based on crystallographic and mass spectrometry analyses results in variants with greater proteolytic robustness. Peptide dosing in cells manifests KDM4A target stabilization. Although further development is required to optimize cellular activity, the results reveal the feasibility of highly-selective non-metal chelating, substrate-competitive inhibitors of the JmjC KDMs. |
| first_indexed | 2024-03-07T00:59:37Z |
| format | Journal article |
| id | oxford-uuid:8945bac1-71aa-42e3-a416-8f0464c4dbba |
| institution | University of Oxford |
| last_indexed | 2024-03-07T00:59:37Z |
| publishDate | 2017 |
| publisher | Nature Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:8945bac1-71aa-42e3-a416-8f0464c4dbba2022-03-26T22:23:23ZHighly selective inhibition of histone demethylases by de novo macrocyclic peptidesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8945bac1-71aa-42e3-a416-8f0464c4dbbaSymplectic Elements at OxfordNature Publishing Group2017Kawamura, AMünzel, MKojima, KYapp, CBhushan, BGoto, YTumber, AKatoh, TKing, OPassioura, TWalport, LHatch, SMadden, SMüller, SBrennan, PChowdhury, RHopkinson, RSuga, HSchofield, CThe JmjC histone demethylases (KDMs) are linked to tumour cell proliferation and are current cancer targets; however, very few highly selective inhibitors for these are available. Here we report cyclic peptide inhibitors of the KDM4A-C with selectivity over other KDMs / 2OG oxygenases, including closely related KDM4D/E isoforms. Crystal structures and biochemical analyses of one of the inhibitors (CP2) with KDM4A reveals that CP2 binds differently to, but competes with, histone substrates in the active site. Substitution of the active site binding arginine of CP2 to N-ε-trimethyl-lysine or methylated-arginine results in cyclic-peptide substrates, indicating that KDM4s may act on non-histone substrates. Targeted modifications to CP2 based on crystallographic and mass spectrometry analyses results in variants with greater proteolytic robustness. Peptide dosing in cells manifests KDM4A target stabilization. Although further development is required to optimize cellular activity, the results reveal the feasibility of highly-selective non-metal chelating, substrate-competitive inhibitors of the JmjC KDMs. |
| spellingShingle | Kawamura, A Münzel, M Kojima, K Yapp, C Bhushan, B Goto, Y Tumber, A Katoh, T King, O Passioura, T Walport, L Hatch, S Madden, S Müller, S Brennan, P Chowdhury, R Hopkinson, R Suga, H Schofield, C Highly selective inhibition of histone demethylases by de novo macrocyclic peptides |
| title | Highly selective inhibition of histone demethylases by de novo macrocyclic peptides |
| title_full | Highly selective inhibition of histone demethylases by de novo macrocyclic peptides |
| title_fullStr | Highly selective inhibition of histone demethylases by de novo macrocyclic peptides |
| title_full_unstemmed | Highly selective inhibition of histone demethylases by de novo macrocyclic peptides |
| title_short | Highly selective inhibition of histone demethylases by de novo macrocyclic peptides |
| title_sort | highly selective inhibition of histone demethylases by de novo macrocyclic peptides |
| work_keys_str_mv | AT kawamuraa highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT munzelm highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT kojimak highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT yappc highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT bhushanb highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT gotoy highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT tumbera highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT katoht highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT kingo highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT passiourat highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT walportl highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT hatchs highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT maddens highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT mullers highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT brennanp highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT chowdhuryr highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT hopkinsonr highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT sugah highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides AT schofieldc highlyselectiveinhibitionofhistonedemethylasesbydenovomacrocyclicpeptides |